The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1560-1562

  Scott, H R ^a   McMillan, D C ^b   Crilly, A ^b   McArdle, C S ^b   Milroy, R ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute phase response; C reactive protein; Interleukin 6; Lung cancer; Platelets

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; WEIGHT REDUCTION;

EID: 0030018821     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.294     Document Type: Article

References (22)

1. AARDEN LA, DE GROOT ER, SCHAAP OL AND LANSDORP PM. (1987). Production of hybridoma growth factor by human monocytes. Eur. J. Immunol., 17, 1411-1416.
2. ESPINOSA E, FELIU J, ZAMORA P, GONZALEZ-BARON M, SANCHEZ JJ, ORDON A AND ESPINOSA J. (1995). Serum albumin and other prognostic factors in patients with advanced non-small cell lung cancer. Lung Cancer, 12, 67-76.
3. FALCONER JS, FEARON KCH, PLESTER CE, ROSS JA AND CARTER DC. (1994a). Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann. Surg., 219, 325-331.
4. FALCONER JS, SLATER C, FEARON KCH, ROSS JA, McMILLAN DC AND PRESTON T. (1994b). Albumin synthesis rates, cytokines and the acute phase response in pancreatic cancer. Clin. Nutr., 13, 33.
5. FALCONER JS, FEARON KCH, PLESTER CE, ROSS JA, ELTON R, WIGMORE SJ, GARDEN OJ AND CARTER DC. (1995). Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer, 75, 2077-2082.
6. FEARON KCH. (1992). The mechanisms and treatment of weight loss in cancer. Proc. Nutr. Soc., 51, 251-265.
7. FEARON KCH, McMILLAN DC, PRESTON T, WINSTANLEY P, CRUICKSHANK AM AND SHENKIN A. (1991). Elevated circulating interleukin 6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann. Surg., 51, 251-265.
8. HEINRIC PC, CASTELL JV AND ANDUS T. (1990). Interleukin-6 and the acute phase response. Biochem. J., 265, 621-636.
9. IHDE DC AND MINNA JD. (1991). Non-small cell lung cancer. Curr. Probl. Cancer, 15, 105-154.
10. McMILLAN DC, PRESTON T, FEARON KCH, BURNS HJG, SLATER C AND SHENKIN A. (1994). Protein synthesis in cancer patients with an inflammatory response: investigations using [15N]glycine. Nutrition, 10, 232-240.
11. McMILLAN DC, LEEN E, SMITH J, STURGEON CM, PRESTON T, COOKE TG AND MARDLE CS. (1995). Effect of extended ibuprofen administration on cortisol, interleukin-6 and the acute phase protein response in colorectal cancer patients. Eur. J. Surg. Oncol., 21, 531-534.
12. MAYER P, GEISSLER K, VALENT P, CESKA M, BETTELHEIM P AND LIEHL E. (1991). Recombinant human interleukin-6 is a potent inducer of the acute phase response and elevates the platelets in nonhuman primates. Exp. Haematol., 19, 688-696.
13. MOUNTAIN CF. (1991). A new international staging system for lung cancer. Chest, 89 (suppl 4), 225-233s.
14. OHE Y, PODACK ER, OLSEN KJ, MIYAHARA Y, MIURA K, SAITO H, KOISHIHARA Y, OHSUGI Y, OHIRA T, NISHIO K AND SAIJO N. (1993). Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shorten survival in syngenic mice. Br. J. Cancer, 67, 939-944.
15. PRESTON T, FEARON KCH, McMILLAN DC, WINSTANLEY FP, SLATER R, SHENKIN A AND CARTER DC. (1995). Effect of ibuprofen on the acute phase response and protein metabolism in patients with cancer and weight loss. Br. J. Surg., 82, 229-234.
16. SELBERG O, McMILLAN DC, PRESTON T, CARSE H, SHENKIN A AND BURNS HJG. (1990). Palmitate turnover and its response to glucose infusion in weight-losing cancer patients. Clin. Nutr., 9, 150-156.
17. SRIDHAR KS, BOUNASSI MJ, RAUB W AND RICHMAN SP. (1990). Clinical features of adenosquamous lung carcinoma in 127 patients. Am. Rev. Resp. Dis., 142, 19-23.
18. SPLINTER TAN. (1991). Management of non small cell lung cancer. Curr. Opin. Oncol., 33, 312-319.
19. STRASSMAN G, FONG M, KENNEY JS AND JACOB CO. (1992). Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J. Clin. Invest., 89, 1681-1684.
20. THOROGOOD J, BULMAN AS, COLLINS T AND ASH D. (1992). The use of discriminant analysis to guide palliative treatment for lung cancer patients. Clin. Oncol. R. Coll. Radiol., 4, 22-26.
21. WIGMORE SJ, FALCONER JS, PLESTER CE, ROSS JA, MAINGAY JP, CARTER DC AND FEARON KCH. (1995). Ibuprofen reduces energy expenditure and acute phase protein production compared with placebo in pancreatic cancer patients. Br. J. Cancer, 72, 185-188.
22. YANAGAWA H, SONE S, TAKAHASHI Y, HAKU T, YANO S, SHINOHARA T AND OGURA T. (1995). Serum levels of interleukin-6 in patients with lung cancer. Br. J. Cancer, 71, 1095-1098.